Dr. Sung Choi on Vorinostat in GVHD Prevention
December 14th 2012Sung W. Choi, MD, Assistant Professor, University of Michigan, discusses the results of a phase I/II trial examining the use of the histone deacetylase (HDAC) inhibitor vorinostat in graft-versus-host disease (GVHD) prevention.
Read More